Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Featured
4.4Very Good
Learn more
TradeStation
4.5Great
Learn more
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Market capitalization
158.95 BUSD
5.99%
—
−0.05USD
2.13 BUSD
58.50 BUSD
5.66 B
Beta (1Y)
0.23
About Pfizer
Sector
CEO
Albert Bourla
Headquarters
New York
Website
Employees (FY)
88 K
Founded
1849
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
Pfizer: This sell off is nowhere near finished Pfizer has been getting pushed like crazy on CNBC by fund managers like Josh Brown as a good buy and after looking at the charts above its very easy to see why. Wallstreet pricks like Brown are trying to offload their last remaining shares on unsuspecting retail buyers. As you can see in the fir
Short
Ready to explode!We have everything in place…A double bottomA channel down breakoutAn inverted head and shoulder forming out
Long
99
Pfizer Combo3 simple potential zones of influence I will be interested in if the price will start descending, for both types of scenarios: consolidations or complete reversals. Also interested in the green curve in case the price finds support there and doesn't look like it can penetrate decisively below after
PFE - Will The Strong Downtrend Ever Be Retested? My thoughts showing how an extended bear move could result in the downward test of a previous bear trend lineI do expect however that one of the green trend lines will hodl so I have put price labels on each of those. It is more likely to continue up than to make this horrid move.Imagine it going
22
PFE Long 1D Conservative Trade DCAConservative Trade "+ long balance- volumed expanding ICE+ support level+ volumed 2Sp-"Monthly context"- short impulse+ 1/2 correction of 15 years long trend+ historical volume- resistance level"There's no trading signal, but I like volume distribution on daily, so started to accumulate
Long
PFIZER, targeting $50! Upside Prospect ON!PFE weekly data is conveying significant accumulation at the current price range.Net positive volume has been increasing on a daily basis for the past few days -- in anticipation of the company's incoming price growth, long term.The stock is currently sitting at 78.6 FIB level -- a discounted le
Long
88
peeking $PFE's levels to manage my positionPfizer Inc. is the best gene therapy stock to buy now.Pfizer expects an FDA decision for Marstacimab, a potential once-weekly subcutaneous treatment for hemophilia B. They also started a Phase 3 study for osivelotor in sickle cell disease.New Product Approvals: Pfizer’s recent product approvals
Long
Pfizer Inc ideaPfizer Inc ideaSafe to enter above $27.18 we may see a new low below $25Technicals are on positive side..
Pfizer (PFE) AnalysisOverview:**Pfizer Inc. (PFE) has been in a prolonged downtrend but is showing signs of potential recovery. The recent chart indicates a bounce from the lows, with key technical indicators suggesting a possible reversal.**Technical Analysis:**1. **Fibonacci Retracement Levels**: - The chart sh
Long
Pfizer !!! low risk , 20% Gain till next month ?? Hello everyone, today I want to discuss Pfizer's stock which experienced a 58% correction from its peak price and is currently trading around $26. I believe this stock has a lot of potential for both scalpers and long-term investors. With a dividend yield of 6.65% at this price, it's an attractive i
Long
11
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where PFE is featured.
Big pharma stocks: Top pharmaceutical firms
Biotech stocks: A shot in the arm
Cancer research stocks: Oncology pharmaceutical market
Covid vaccine stocks: Jabtastic
Recession-proof stocks: Bucking the trend
Sex stocks: Full exposure
US stocks: All-American heroes
The current price of
PFE
is
28.05
USD
— it has increased by
1.26
% in the past 24 hours. Watch
Pfizer
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
NYSE
exchange
Pfizer
stocks are traded under the ticker
PFE
.
PFE
stock has risen by
0.97
% compared to the previous week, the month change is a
5.11
% fall, over the last year
Pfizer
has showed a
22.51
% decrease.
We've gathered analysts' opinions on
Pfizer
future price: according to them,
PFE
price has a max estimate of
53.00
USD
and a min estimate of
27.00
USD
. Watch
PFE chartand read a more detailed
Pfizer stock forecast: see what analysts think of
Pfizer
and suggest that you do with its stocks.
PFE
reached its all-time high on
Dec 20, 2021
with the price of
61.71
USD
, and its all-time low was
0.38
USD
and was reached on
Mar 14, 1968
. View more price dynamics on
PFE chart.
See other stocks reaching their highest and lowest prices.
PFE
stock is
1.52
% volatile and has beta coefficient of
0.23
. Track
Pfizer
stock price on the chart and check out the list of the most volatile stocks — is
Pfizer
there?
Today
Pfizer
has the market capitalization of
156.97 B
, it has decreased by
1.15
% over the last week.
Yes, you can track
Pfizer financialsin yearly and quarterly reports right on TradingView.
Pfizer
is going to release the next earnings report on
Jul 30, 2024
. Keep track of upcoming events with our Earnings Calendar.
PFE
earnings for the last quarter are
0.82
USD
per share, whereas the estimation was
0.52
USD
resulting in a
58.97
% surprise. The estimated earnings for the next quarter are
0.45
USD
per share. See more details about
Pfizer earnings.
for the last quarter amounts to
14.88 B
USD
, despite the estimated figure of
13.87 B
USD
. In the next quarter, revenue is expected to reach
13.07 B
USD
.
PFE
net income for the last quarter is
3.12 B
USD
, while the quarter before that showed
−3.34 B
USD
of net income which accounts for
193.30
% change. Track more
Pfizer financial statsto get the full picture.
Yes,
PFE
dividends are paid quarterly. The last dividend per share was
0.42
USD
. As of today, Dividend Yield (TTM)% is
5.99
%. Tracking
Pfizer dividendsmight help you take more informed decisions.
Pfizer
dividend yield was
5.73
% in
2023
, and payout ratio reached
439.41
%. The year before the numbers were
3.14
% and
29.43
% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of
Jul 7, 2024
, the company has
88.00 K
employees. See our rating of the largest employees — is
Pfizer
on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
Pfizer
EBITDA is
8.32 B
USD
, and current EBITDA margin is
17.99
%. See more stats in
Pfizer financial statements.
Like other stocks,
PFE
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
Pfizer
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
Pfizer
technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
Pfizer
stock shows the sell signal. See more of
Pfizer technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
